The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
09 02 2021
Historique:
entrez: 21 1 2021
pubmed: 22 1 2021
medline: 2 2 2021
Statut: ppublish

Résumé

The COVID-19 pandemic has the potential to affect the human microbiome in infected and uninfected individuals, having a substantial impact on human health over the long term. This pandemic intersects with a decades-long decline in microbial diversity and ancestral microbes due to hygiene, antibiotics, and urban living (the hygiene hypothesis). High-risk groups succumbing to COVID-19 include those with preexisting conditions, such as diabetes and obesity, which are also associated with microbiome abnormalities. Current pandemic control measures and practices will have broad, uneven, and potentially long-term effects for the human microbiome across the planet, given the implementation of physical separation, extensive hygiene, travel barriers, and other measures that influence overall microbial loss and inability for reinoculation. Although much remains uncertain or unknown about the virus and its consequences, implementing pandemic control practices could significantly affect the microbiome. In this Perspective, we explore many facets of COVID-19-induced societal changes and their possible effects on the microbiome, and discuss current and future challenges regarding the interplay between this pandemic and the microbiome. Recent recognition of the microbiome's influence on human health makes it critical to consider both how the microbiome, shaped by biosocial processes, affects susceptibility to the coronavirus and, conversely, how COVID-19 disease and prevention measures may affect the microbiome. This knowledge may prove key in prevention and treatment, and long-term biological and social outcomes of this pandemic.

Identifiants

pubmed: 33472859
pii: 2010217118
doi: 10.1073/pnas.2010217118
pmc: PMC8017729
pii:
doi:

Substances chimiques

Anti-Infective Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIGMS NIH HHS
ID : P01 GM125576
Pays : United States

Commentaires et corrections

Type : ErratumIn

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

Front Immunol. 2020 Jul 07;11:1672
pubmed: 32733490
Dig Dis Sci. 2020 Mar;65(3):723-740
pubmed: 32060812
J Allergy Clin Immunol. 2012 Jun;129(6):1470-7.e6
pubmed: 22534534
Sci Transl Med. 2016 Jun 15;8(343):343ra82
pubmed: 27306664
PLoS Med. 2018 Jan 23;15(1):e1002494
pubmed: 29360829
Microbiome. 2017 Jul 14;5(1):76
pubmed: 28705228
ILAR J. 2017 Dec 15;58(3):315-318
pubmed: 29253148
Trends Ecol Evol. 2018 Dec;33(12):926-935
pubmed: 30266244
Foods. 2020 Apr 22;9(4):
pubmed: 32331259
Am J Ind Med. 2020 Sep;63(9):817-820
pubmed: 32539166
Science. 2015 Aug 28;349(6251):989-93
pubmed: 26160380
Cell Host Microbe. 2013 Nov 13;14(5):559-70
pubmed: 24237701
Nature. 2018 Mar 29;555(7698):623-628
pubmed: 29555994
Clin Microbiol Infect. 2020 Jun;26(6):767-772
pubmed: 32304745
Ultrasound Obstet Gynecol. 2020 Jul;56(1):15-27
pubmed: 32430957
Aliment Pharmacol Ther. 2018 Feb;47(3):332-345
pubmed: 29205415
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):644-645
pubmed: 32339473
Inflamm Bowel Dis. 2020 Aug 20;26(9):1306-1314
pubmed: 32720978
Nat Rev Microbiol. 2020 Aug;18(8):409-410
pubmed: 32488173
Nat Rev Immunol. 2017 Apr;17(4):219-232
pubmed: 28260787
MMWR Morb Mortal Wkly Rep. 2020 May 08;69(18):
pubmed: 32379731
Qual Health Res. 2016 Jan;26(2):164-75
pubmed: 25646000
Science. 2020 Jan 17;367(6475):250-251
pubmed: 31949069
Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):1433-1436
pubmed: 28196925
Cell Rep. 2020 Jul 21;32(3):107915
pubmed: 32649864
BMC Public Health. 2019 Jun 13;19(Suppl 4):549
pubmed: 31196023
J Am Geriatr Soc. 2015 Apr;63(4):776-81
pubmed: 25851728
BMJ Glob Health. 2019 Aug 15;4(4):e001590
pubmed: 31497315
J Allergy Clin Immunol. 2020 Jul;146(1):110-118
pubmed: 32294485
Nat Microbiol. 2019 Jun;4(6):964-971
pubmed: 30911128
MMWR Morb Mortal Wkly Rep. 2020 May 22;69(20):630-631
pubmed: 32437340
Chronobiol Int. 2020 Jul;37(7):1067-1081
pubmed: 32602753
BJOG. 2020 Jul;127(8):927-929
pubmed: 32219995
Emerg Infect Dis. 2013 Feb;19(2):254-9
pubmed: 23343512
Am J Trop Med Hyg. 2020 Jun;102(6):1184-1188
pubmed: 32323646
Lancet. 2020 Mar 14;395(10227):846-848
pubmed: 32151325
Science. 2020 May 15;368(6492):700-703
pubmed: 32409457
Nutrients. 2020 Jun 10;12(6):
pubmed: 32531892
EMBO Rep. 2018 Jun;19(6):
pubmed: 29777052
Obstet Gynecol. 2020 Aug;136(2):262-272
pubmed: 32544146
OMICS. 2018 Feb;22(2):90-107
pubmed: 28767318
Microbiome. 2017 Jul 14;5(1):80
pubmed: 28709450
Nat Commun. 2020 Apr 20;11(1):1904
pubmed: 32312972
Nat Rev Microbiol. 2018 Nov;16(11):661-670
pubmed: 30127345
Public Health Nutr. 2017 Jan;20(1):183-189
pubmed: 27406399
BMJ. 1989 Nov 18;299(6710):1259-60
pubmed: 2513902
Sci Adv. 2015 Apr 3;1(3):
pubmed: 26229982
Nat Med. 2020 Jul;26(7):1077-1083
pubmed: 32405028
Antimicrob Resist Infect Control. 2020 May 20;9(1):71
pubmed: 32434591
Am J Infect Control. 2020 Sep;48(9):1090-1099
pubmed: 32311380
Cell Host Microbe. 2020 Aug 12;28(2):285-297.e4
pubmed: 32652062
Med Hypotheses. 2020 Nov;144:110209
pubmed: 33254516
Matern Child Nutr. 2020 Oct;16(4):e13033
pubmed: 32458558
Cell Host Microbe. 2020 Jun 10;27(6):870-878
pubmed: 32464097
PLoS One. 2017 Feb 2;12(2):e0171017
pubmed: 28152044
J Transl Med. 2020 Jun 8;18(1):229
pubmed: 32513197
Annu Rev Genet. 2019 Dec 3;53:239-261
pubmed: 31487470
Res Rep Trop Med. 2020 Sep 17;11:61-72
pubmed: 32982538
Immunotargets Ther. 2015 Jul 27;4:143-57
pubmed: 27471720
Ann N Y Acad Sci. 2010 Feb;1186:69-101
pubmed: 20201869
Front Immunol. 2020 May 01;11:827
pubmed: 32425950
Genes (Basel). 2018 Nov 06;9(11):
pubmed: 30404178
Environ Health Perspect. 2020 May;128(5):57005
pubmed: 32438824
Gastroenterology. 2020 Sep;159(3):944-955.e8
pubmed: 32442562
Int J Equity Health. 2020 Jun 3;19(1):82
pubmed: 32493409
Gut Microbes. 2017 Mar 4;8(2):82-97
pubmed: 27808595
Dig Dis. 2011;29(2):144-53
pubmed: 21734378
Obesity (Silver Spring). 2020 Jun;28(6):1008-1009
pubmed: 32227671
Science. 2019 Oct 25;366(6464):
pubmed: 31649168
J Public Health (Oxf). 2020 Aug 18;42(3):451-460
pubmed: 32556213
Trends Parasitol. 2019 Oct;35(10):809-821
pubmed: 31451407
Science. 2020 Jul 3;369(6499):50-54
pubmed: 32358202
Nat Rev Microbiol. 2009 Dec;7(12):887-94
pubmed: 19898491
Cell Metab. 2014 Dec 2;20(6):1006-17
pubmed: 25470548
Nature. 2016 Jan 14;529(7585):212-5
pubmed: 26762459
J Urban Health. 2020 Jun;97(3):348-357
pubmed: 32333243
Perspect Psychol Sci. 2015 Mar;10(2):227-37
pubmed: 25910392
Lancet. 2020 Jan 4;395(10217):65-74
pubmed: 31852602
Proc Natl Acad Sci U S A. 2018 Sep 4;115(36):E8489-E8498
pubmed: 30126990
Cell. 2018 Nov 1;175(4):962-972.e10
pubmed: 30388453
CMAJ. 2018 Sep 17;190(37):E1097-E1107
pubmed: 30224442

Auteurs

B Brett Finlay (BB)

Michael Smith Laboratories, University of British Columbia, Vancouver, BC V6T 1Z4, Canada; bfinlay@msl.ubc.ca tamara.giles-vernick@pasteur.fr.
Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.

Katherine R Amato (KR)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Department of Anthropology, Northwestern University, Evanston, IL 60208.

Meghan Azad (M)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Manitoba Interdisciplinary Lactation Centre, Children's Hospital Research Institute of Manitoba, Winnipeg, MB R3E 3P4, Canada.

Martin J Blaser (MJ)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Center for Advanced Biotechnology and Medicine at Rutgers Biomedical and Health Sciences, Rutgers University, Piscataway, NJ 08854-8021.

Thomas C G Bosch (TCG)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Zoologisches Institut, University of Kiel, 24118 Kiel, Germany.

Hiutung Chu (H)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Department of Pathology, University of California San Diego, La Jolla, CA 92093.

Maria Gloria Dominguez-Bello (MG)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Department of Biochemistry and Microbiology, Rutgers University, New Brunswick, NJ 08901.

Stanislav Dusko Ehrlich (SD)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Metagenopolis Unit, French National Institute for Agricultural Research, 78350 Jouy-en-Josas, France.

Eran Elinav (E)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Department of Immunology, Weizmann Institute of Science, Rehovot 761000, Israel.
Cancer-Microbiome Division, Deutsches Krebsforschungszentrum, 69120 Heidelberg, Germany.

Naama Geva-Zatorsky (N)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Technion Integrated Cancer Center, Department of Cell Biology and Cancer Science, Technion-Israel Institute of Technology, Haifa 3525433, Israel.

Philippe Gros (P)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Department of Biochemistry, McGill University, Montreal, QC H3G 1Y6, Canada.

Karen Guillemin (K)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Institute of Molecular Biology, University of Oregon, Eugene, OR 97403.

Frédéric Keck (F)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Centre National de la Recherche Scientifique, 75016 Paris, France.
Laboratoire d'Anthropologie Sociale, Collège de France, 75005 Paris, France.

Tal Korem (T)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Department of Systems Biology, Irving Cancer Research Center, Columbia University, New York, NY 10032.
Department of Obstetrics and Gynecology, Irving Cancer Research Center, Columbia University, New York, NY 10032.

Margaret J McFall-Ngai (MJ)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Pacific Biosciences Research Center, University of Hawai'i at Manoa, Honolulu, HI 96822.

Melissa K Melby (MK)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Department of Anthropology, University of Delaware, Newark, DE 19711.

Mark Nichter (M)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Department of Anthropology, University of Arizona, Tucson, AZ 85721.

Sven Pettersson (S)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Lee Kong Chian School of Medicine, Nanyang Technological University, 637715 Singapore.

Hendrik Poinar (H)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Department of Anthropology, McMaster University, Hamilton, ON L8S 4M4, Canada.

Tobias Rees (T)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Transformations of the Human Program, Berggruen Institute, Los Angeles, CA 90013.

Carolina Tropini (C)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
School of Biomedical Engineering, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Department of Microbiology & Immunology, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.

Liping Zhao (L)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Department of Biochemistry and Microbiology, Rutgers University, New Brunswick, NJ 08901.

Tamara Giles-Vernick (T)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada; bfinlay@msl.ubc.ca tamara.giles-vernick@pasteur.fr.
Anthropology & Ecology of Disease Emergence, Institut Pasteur, 75015 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH